Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2031250388) titled 'A study of DS3610a in Participants with Advanced Solid Tumor' on Sept. 25.
Study Type: Interventional
Study Design:
non-randomized controlled trial, open(masking not used), uncontrolled control, single assignment, treatment purpose
Primary Sponsor: Inoguchi Akihiro
Condition:
Solid tumors, Metastatic solid tumors
Intervention:
Experimental: DS3610a at Escalating Doses
Participants will receive DS3610a at escalating doses.
The RDE will be determined usingdata collected from this arm.
Participants will receive DS3610a at the target dose. Treatment will continue until radiographic disease progression, as ...